Schulze_2010_Bioorg.Med.Chem.Lett_20_2946

Reference

Title : Bivalent 5,8,9,13b-tetrahydro-6H-isoquino[1,2-a]isoquinolines and -isoquinolinium salts: novel heterocyclic templates for butyrylcholinesterase inhibitors - Schulze_2010_Bioorg.Med.Chem.Lett_20_2946
Author(s) : Schulze M , Siol O , Decker M , Lehmann J
Ref : Bioorganic & Medicinal Chemistry Lett , 20 :2946 , 2010
Abstract :

Three different types of homobivalent compounds, 5,8,9,13b-tetrahydro-6H-isoqino[1,2-a]isoquinolines bearing tertiary N-atoms, their quaternary ammonium salts and their dibenzazecine analogues, connected by alkylene spacers of various lengths were synthesized. Compared to the therapeutically used inhibitor galanthamine, some of the bivalent compounds showed much higher inhibitory activities at both cholinesterases in the Ellman test. Surprisingly, not only the quaternary salts, but also the uncharged tertiary compounds exhibited IC(50) values at butyrylcholinesterase in the nanomolar range. Selectivity toward BChE of up to 76-fold was observed.

PubMedSearch : Schulze_2010_Bioorg.Med.Chem.Lett_20_2946
PubMedID: 20350808

Related information

Citations formats

Schulze M, Siol O, Decker M, Lehmann J (2010)
Bivalent 5,8,9,13b-tetrahydro-6H-isoquino[1,2-a]isoquinolines and -isoquinolinium salts: novel heterocyclic templates for butyrylcholinesterase inhibitors
Bioorganic & Medicinal Chemistry Lett 20 :2946

Schulze M, Siol O, Decker M, Lehmann J (2010)
Bioorganic & Medicinal Chemistry Lett 20 :2946